Evaluation of a new gamma camera system
Evaluation of the Veriton SPECT/CT System
NA · Mayo Clinic · NCT04722185
This study is testing a new gamma camera system to see if it can take better pictures for nuclear medicine exams than the regular cameras currently used.
Quick facts
| Phase | NA |
|---|---|
| Study type | Interventional |
| Enrollment | 300 (estimated) |
| Ages | 18 Years and up |
| Sex | All |
| Sponsor | Mayo Clinic (other) |
| Locations | 1 site (Rochester, Minnesota) |
| Trial ID | NCT04722185 on ClinicalTrials.gov |
What this trial studies
This study evaluates the Veriton SPECT/CT system, a new type of gamma camera designed to enhance system sensitivity and improve image quality compared to conventional gamma cameras. The goal is to determine if the Veriton system can achieve equal or better image quality than standard SPECT/CT systems. Participants will undergo a nuclear medicine exam using the Veriton system to assess its performance. The study aims to provide insights into the effectiveness of this innovative imaging technology.
Who should consider this trial
Good fit: Ideal candidates for this study are adults aged 18 years or older who are scheduled for a nuclear medicine exam.
Not a fit: Patients under 18 years of age or those unable to provide informed consent will not benefit from this study.
Why it matters
Potential benefit: If successful, this study could lead to improved diagnostic imaging for patients undergoing nuclear medicine exams.
How similar studies have performed: While this approach is innovative, similar studies evaluating new imaging technologies have shown promise in enhancing diagnostic capabilities.
Eligibility criteria
Show full inclusion / exclusion criteria
Inclusion Criteria: * Adults age 18 years or older. * Currently scheduled to undergo a nuclear medicine exam. Exclusion Criteria: * Individuals under 18 years of age. * Unwilling/unable to sign an informed consent form. * Unable to lie on a Veriton imaging table for up to 40 minutes.
Where this trial is running
Rochester, Minnesota
- Mayo Clinic in Rochester — Rochester, Minnesota, United States (RECRUITING)
Study contacts
- Principal investigator: Carrie Hruska, PhD — Mayo Clinic
- Study coordinator: Kera Delaney
- Email: Delaney.Kera@mayo.edu
- Phone: 507-293-5660
How to participate
- Review the eligibility criteria above with your treating physician.
- Visit the official trial page on ClinicalTrials.gov for the most current contact information and recruitment status.
- Contact the listed study coordinator or principal investigator to request pre-screening. Pre-screening is free and never obligates you to enroll.
Conditions: Focus of Study is Comparison of 2 Types of Gamma Cameras